Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Hypotensive effects of statins. A place for hydrogen sulfide in the puzzle?

Wiliński B, Wiliński J, Somogyi E.

Folia Med Cracov. 2011;51(1-4):37-43. Review.

PMID:
22891536
[PubMed - indexed for MEDLINE]
2.

Atorvastatin affects the tissue concentration of hydrogen sulfide in mouse kidneys and other organs.

Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M.

Pharmacol Rep. 2011;63(1):184-8.

PMID:
21441627
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential effects of statins on endogenous H2S formation in perivascular adipose tissue.

Wójcicka G, Jamroz-Wiśniewska A, Atanasova P, Chaldakov GN, Chylińska-Kula B, Bełtowski J.

Pharmacol Res. 2011 Jan;63(1):68-76. doi: 10.1016/j.phrs.2010.10.011. Epub 2010 Oct 20.

PMID:
20969959
[PubMed - indexed for MEDLINE]
4.

Atorvastatin: pharmacological characteristics and lipid-lowering effects.

Poli A.

Drugs. 2007;67 Suppl 1:3-15. Review.

PMID:
17910517
[PubMed - indexed for MEDLINE]
5.

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.

Krysiak R, Okopień B, Herman Z.

Drugs. 2003;63(17):1821-54. Review.

PMID:
12921488
[PubMed - indexed for MEDLINE]
6.

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.

Epstein M, Campese VM.

Am J Kidney Dis. 2005 Jan;45(1):2-14. Review.

PMID:
15696439
[PubMed - indexed for MEDLINE]
7.

Effects of statin therapy on the progression of chronic kidney disease.

Shah S, Paparello J, Danesh FR.

Adv Chronic Kidney Dis. 2005 Apr;12(2):187-95. Review.

PMID:
15822054
[PubMed - indexed for MEDLINE]
8.

Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.

Pedersen TR.

Am J Cardiovasc Drugs. 2010;10 Suppl 1:10-7. doi: 10.2165/1158822-S0-000000000-00000. Review.

PMID:
21391729
[PubMed - indexed for MEDLINE]
9.

Statins and plaque stability.

Gomberg-Maitland M, Fuster V, Fayad ZA, Badimon JJ, Corti R.

J Cardiovasc Risk. 2003 Jun;10(3):161-7. Review.

PMID:
12775948
[PubMed - indexed for MEDLINE]
10.

Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

Moghadasian MH.

Life Sci. 1999;65(13):1329-37. Review.

PMID:
10503952
[PubMed - indexed for MEDLINE]
11.

HMG-CoA reductase inhibitors and the kidney.

Campese VM, Park J.

Kidney Int. 2007 Jun;71(12):1215-22. Epub 2007 May 9. Review.

PMID:
17495867
[PubMed - indexed for MEDLINE]
12.

[The non-lipid effects of statins].

Paragh G, Márk L, Katona E.

Orv Hetil. 2004 Sep 12;145(37):1903-10. Review. Hungarian.

PMID:
15493621
[PubMed - indexed for MEDLINE]
13.

Atorvastatin and diabetic vascular complications.

Yamagishi S, Matsui T, Nakamura K.

Curr Pharm Des. 2006;12(12):1549-54. Review.

PMID:
16611135
[PubMed - indexed for MEDLINE]
14.

Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.

Mason RP, Walter MF, Day CA, Jacob RF.

Am J Cardiol. 2005 Sep 5;96(5A):11F-23F. Review.

PMID:
16126019
[PubMed - indexed for MEDLINE]
15.

The role of pleiotropic effects of statins in dementia.

Crisby M.

Acta Neurol Scand Suppl. 2006;185:115-8. Review.

PMID:
16866920
[PubMed - indexed for MEDLINE]
16.

Statin therapy-evidence beyond lipid lowering contributing to plaque stability.

de Lorenzo F, Feher M, Martin J, Collot-Teixeira S, Dotsenko O, McGregor JL.

Curr Med Chem. 2006;13(28):3385-93. Review.

PMID:
17168712
[PubMed - indexed for MEDLINE]
17.

Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.

Varughese GI, Patel JV, Lip GY, Varma C.

Curr Pharm Des. 2006;12(13):1593-609. Review.

PMID:
16729872
[PubMed - indexed for MEDLINE]
18.

Antioxidant effects of statins.

Stoll LL, McCormick ML, Denning GM, Weintraub NL.

Drugs Today (Barc). 2004 Dec;40(12):975-90. Review.

PMID:
15645009
[PubMed - indexed for MEDLINE]
19.

Role and significance of statins in the treatment of hypertensive patients.

Stepien M, Banach M, Mikhailidis DP, Gluba A, Kjeldsen SE, Rysz J.

Curr Med Res Opin. 2009 Aug;25(8):1995-2005. doi: 10.1185/03007990903098081. Review.

PMID:
19555312
[PubMed - indexed for MEDLINE]
20.

Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.

Danesh FR, Kanwar YS.

FASEB J. 2004 May;18(7):805-15. Review.

PMID:
15117885
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk